Fidelity Investments’s AGF US Market Neutral Anti-Beta Fund BTAL Stock Holding History
Bought
Maintained
Sold
Other funds holding BTAL
FDCDDQ
CCA
AWM
KF
OIA
CGA
IA
Fidelity Investments's BTAL Position: Q2 2026 in Review
Fidelity Investments held its AGF US Market Neutral Anti-Beta Fund (BTAL) position steady in Q2 2026 at 1,944,444 shares worth $21.7M. The position accounts for ﹤0.01% of the portfolio, ranked #1855.
Fidelity Investments first reported a position in BTAL in Q3 2020 and has held it in 12 quarters since. The position peaked at $34.4M in Q2 2025. 93 funds tracked by Wall St. Rank hold BTAL as of Q2 2026.
- Fidelity Investments held 1,944,444 shares of AGF US Market Neutral Anti-Beta Fund worth $21.7M as of Q2 2026.
- Fidelity Investments left its AGF US Market Neutral Anti-Beta Fund share count unchanged in Q2 2026.
- AGF US Market Neutral Anti-Beta Fund made up ﹤0.01% of Fidelity Investments's portfolio in Q2 2026, its #1855 holding.
- Fidelity Investments first reported a position in AGF US Market Neutral Anti-Beta Fund in Q3 2020 and has held it in 12 quarters since.
- Fidelity Investments's AGF US Market Neutral Anti-Beta Fund position peaked at $34.4M in Q2 2025.
- 93 funds tracked by Wall St. Rank held AGF US Market Neutral Anti-Beta Fund as of Q2 2026.
Based on Fidelity Investments's 13F filing for Q2 2026, filed 13 Aug 2026.